{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:26:53Z","timestamp":1787776013530,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Aim:<\/jats:title>\n                    <jats:p>Pancreatic cancer (PC) remains one of the most aggressive malignancies worldwide, characterized by rapid disease progression and a dismal prognosis. Despite therapeutic advancements, the development of chemoresistance, particularly to platinum-based agents such as carboplatin, poses a major obstacle to effective clinical management. LINC00963 has been implicated in cancer cell proliferation and drug resistance, although its specific function and underlying mechanisms in PC remain insufficiently explored. The purpose of this paper is to analyze the impact ofLINC00963 on the malignant progression of PC and carboplatin sensibility and the underlying mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The purpose of this paper is to enquire the biologic impact of long intergenic non-coding RNA 00963 (LINC00963) in pancreatic cancer (PC) cell evolution and carboplatin sensibility through controlling microRNA (miR)-495-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>LINC00963 and miR-495-3p levels in PC cells were tested via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Cell counting kit (CCK)-8 assay monitored cell viability and half maximal inhibitory concentration (IC50) value for carboplatin. Cell clone number detection using colony formation assay and apoptosis rate detection using flow cytometry were proceeded. Dual luciferase reporter test verified the targeted relation of LINC00963 and miR-495-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>LINC00963 enhancement and miR-495-3p weakening were found in PC cells. After interfering LINC00963, cell survival, clone numbers, and the IC50 value to carboplatin were decreased, and cell apoptosis rate and miR-495-3p abundance were increased. LINC00963 could reversely adjust miR-495-3p. Cell viability, clone numbers, and the IC50 value to carboplatin were declined, and apoptotic cell numbers were enhanced after miR-495-3p overexpression. The inhibition of miR-495-3p visibly mitigated the influence of LINC00963 interference on cell viability, clone numbers, apoptotic rate, and the IC50 value to carboplatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>LINC00963 downregulation could block PC cell progression and elevate their sensitivity to carboplatin through accelerating miR-495-3p level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_886_24","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:00:19Z","timestamp":1772604019000},"page":"204-211","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["LINC00963 Targets miR-495-3p to Regulate Pancreatic Cancer Cell Proliferation, Apoptosis, and Carboplatin Sensitivity"],"prefix":"10.4103","volume":"29","author":[{"given":"J","family":"Hu","sequence":"first","affiliation":[{"name":"The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Shan","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"},{"name":"Department of Gastrointestinal Surgery, The Affiliated Hospital of Medical School of Westlake University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"R1-20260416","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"S1","key":"R2-20260416","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.21037\/cco.2019.08.01","article-title":"Chemotherapy of pancreatic cancer in patients with poor performance","volume":"8","author":"Schulz","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R3-20260416","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00535-020-01666-y","article-title":"Recent advances in chemotherapy for pancreatic cancer: Evidence from Japan and recommendations in guidelines","volume":"55","author":"Okusaka","year":"2020","journal-title":"J Gastroenterol"},{"key":"R4-20260416","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5326\/15473317-36-1-13","article-title":"Carboplatin","volume":"36","author":"Fox","year":"2000","journal-title":"J Am Anim Hosp Assoc"},{"key":"R5-20260416","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11033-021-06603-7","article-title":"LncRNA as a multifunctional regulator in cancer multi-drug resistance","volume":"48","author":"He","year":"2021","journal-title":"Mol Biol Rep"},{"key":"R6-20260416","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/cells8091015","article-title":"Long non-coding RNA in the pathogenesis of cancers","volume":"8","author":"Chi","year":"2019","journal-title":"Cells"},{"key":"R7-20260416","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R8-20260416","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/CMAR.S229083","article-title":"LINC00963 promotes ovarian cancer proliferation, migration and EMT via the miR-378g\/CHI3L1 axis","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R9-20260416","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/cancers12051073","article-title":"LINC00963 promotes cancer stemness, metastasis, and drug resistance in head and neck carcinomas via ABCB5 regulation","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R10-20260416","doi-asserted-by":"crossref","first-page":"19582","DOI":"10.1002\/jcp.28557","article-title":"NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo","volume":"234","author":"He","year":"2019","journal-title":"J Cell Physiol"},{"key":"R11-20260416","first-page":"9408","article-title":"LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p","volume":"24","author":"Huang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R12-20260416","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2020.09.074","article-title":"LINC01133 contributes to epithelial ovarian cancer metastasis by regulating miR-495-3p\/TPD52 axis","volume":"533","author":"Liu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-20260416","first-page":"E9","article-title":"Compatibility and stability of nab-paclitaxel in combination with other drugs","volume":"63","author":"Mizuta","year":"2017","journal-title":"Kobe J Med Sci"},{"key":"R14-20260416","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","article-title":"LncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions","volume":"75","author":"McCabe","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"R15-20260416","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.drudis.2022.05.012","article-title":"Long noncoding RNAs (lncRNAs) in pancreatic cancer progression","volume":"27","author":"Ashrafizadeh","year":"2022","journal-title":"Drug Discov Today"},{"key":"R16-20260416","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41420-022-01061-x","article-title":"The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer","volume":"8","author":"Xu","year":"2022","journal-title":"Cell Death Discov"},{"key":"R17-20260416","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2017.09.019","article-title":"LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9","volume":"410","author":"Fu","year":"2017","journal-title":"Cancer Lett"},{"key":"R18-20260416","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/beta-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"R19-20260416","first-page":"164","article-title":"LINC00963 predicts poor prognosis and promotes esophageal cancer cells invasion via targeting miR-214-5p\/RAB14 axis","volume":"24","author":"Liu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R20-20260416","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/CMAR.S249979","article-title":"LINC00963 functions as an oncogene in bladder cancer by regulating the miR-766-3p\/MTA1 axis","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R21-20260416","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.omtn.2019.09.033","article-title":"LncRNA LINC00963 promotes tumorigenesis and radioresistance in breast cancer by sponging miR-324-3p and inducing ACK1 expression","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"R22-20260416","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/15384101.2020.1728024","article-title":"Long noncoding RNA LINC00963 promotes breast cancer progression by functioning as a molecular sponge for microRNA-625 and thereby upregulating HMGA1","volume":"19","author":"Wu","year":"2020","journal-title":"Cell Cycle"},{"key":"R23-20260416","doi-asserted-by":"crossref","first-page":"12999","DOI":"10.2147\/OTT.S274708","article-title":"Long noncoding RNA LINC00963 promotes CDC5L-mediated malignant progression in gastric cancer","volume":"13","author":"Zhu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"R24-20260416","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13048-021-00856-3","article-title":"GATA1-induced upregulation of LINC01503 promotes carboplatin resistance in ovarian carcinoma by upregulating PD-L1 via sponging miR-766-5p","volume":"14","author":"Li","year":"2021","journal-title":"J Ovarian Res"},{"key":"R25-20260416","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3802\/jgo.2022.33.e81","article-title":"LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p\/FOXP1 axis","volume":"33","author":"Xia","year":"2022","journal-title":"J Gynecol Oncol"},{"key":"R26-20260416","doi-asserted-by":"crossref","first-page":"113609","DOI":"10.1016\/j.biopha.2022.113609","article-title":"LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions","volume":"154","author":"Entezari","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R27-20260416","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ijms19051310","article-title":"Noncoding RNA: RNA regulatory networks in cancer","volume":"19","author":"Chan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R28-20260416","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/cells10061361","article-title":"Extracellular vesicles and pancreatic cancer: Insights on the roles of miRNA, lncRNA, and protein cargos in cancer progression","volume":"10","author":"Romano","year":"2021","journal-title":"Cells"},{"key":"R29-20260416","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.18632\/aging.101933","article-title":"A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer","volume":"11","author":"Wang","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"R30-20260416","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s12094-021-02687-6","article-title":"MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer","volume":"23","author":"Tang","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"R31-20260416","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41419-018-0950-x","article-title":"MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78\/mTOR axis in gastric cancer","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis"},{"key":"R32-20260416","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s10620-020-06576-w","article-title":"SNHG10 promotes cell proliferation and migration in gastric cancer by targeting miR-495-3p\/CTNNB1 axis","volume":"66","author":"Yuan","year":"2021","journal-title":"Dig Dis Sci"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_886_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:48:32Z","timestamp":1787773712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_886_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_886_24","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"2024-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}